St. Jude Medical (STJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
Cash Flows From Operating Activities | |||||
Net Income | 393,490 | 409,934 | 336,779 | 276,285 | 172,592 |
Depreciation Amortization | 130,209 | 85,755 | 76,683 | 74,920 | 90,299 |
Income taxes - deferred | 4,833 | -9,340 | 33,146 | 37,695 | -11,681 |
Accounts receivable | -138,846 | -102,405 | -31,315 | -39,146 | -23,941 |
Other Working Capital | 18,652 | 66,208 | 25,065 | 28,300 | 16,091 |
Other Operating Activity | 307,975 | 154,130 | 33,927 | 39,146 | 66,775 |
Operating Cash Flow | $716,313 | $604,282 | $474,285 | $417,200 | $310,135 |
Cash Flows From Investing Activities | |||||
PPE Investments | -158,768 | -89,468 | -49,565 | -62,176 | -63,129 |
Net Acquisitions | -1,775,527 | -249,941 | -230,839 | -29,500 | -20,444 |
Sale Of Investment | 153,389 | N/A | N/A | 7,000 | 15,000 |
Other Investing Activity | -29,864 | -68,399 | -66,196 | -31,088 | -26,220 |
Investing Cash Flow | $-1,810,770 | $-407,808 | $-346,600 | $-115,764 | $-94,793 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | -11,964 | 9,454 | N/A | N/A |
Debt Issued | 4,037,775 | 2,285,775 | 1,284,800 | 352,000 | 2,115,028 |
Debt Repayment | -3,195,718 | -2,409,200 | -954,050 | -475,128 | -2,286,400 |
Common Stock Issued | 126,113 | 146,143 | 89,702 | 66,005 | 57,941 |
Common Stock Repurchased | N/A | N/A | -520,025 | N/A | N/A |
Financing Cash Flow | $968,170 | $10,754 | $-90,119 | $-57,123 | $-113,431 |
Exchange Rate Effect | -27,185 | 19,559 | 21,827 | 9,212 | -4,015 |
Beginning Cash Position | 688,040 | 461,253 | 401,860 | 148,335 | 50,439 |
End Cash Position | 534,568 | 688,040 | 461,253 | 401,860 | 148,335 |
Net Cash Flow | $-153,472 | $226,787 | $59,393 | $253,525 | $97,896 |
Free Cash Flow | |||||
Operating Cash Flow | 716,313 | 604,282 | 474,285 | 417,200 | 310,135 |
Capital Expenditure | -158,768 | -89,468 | -49,565 | -62,176 | -63,129 |
Free Cash Flow | 557,545 | 514,814 | 424,720 | 355,024 | 247,006 |